Sleep Apnea Devices Market Analysis

Product Type (Diagnostic Devices, Therapeutic Devices, Sleep Apnea Masks)

The global sleep apnea devices market is segmented and analyzed for demand and supply by type into therapeutic devices, diagnostic devices, and sleep apnea masks. Out of these, the sleep apnea masks are anticipated to hold the largest market size by the end of 2037. The segment growth is primarily attributed to the rising prevalence of comorbidities associated with obstructive sleep apnea (OSA), and rising adoption rates of CPAP machines in disease management. As per research, it is estimated that 936 million adults aged 30-69 years (men and women) have mild to moderate obstructive sleep apnea and over 425 million adults aged 30-69 years have moderate to severe obstructive sleep apnea globally.

Major Macro-Economic Indicators Impacting the Market Growth

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Our in-depth analysis of the global market includes the following segments:

By Disease Type	Obstructive Sleep Apnea Syndrome Central Sleep Apnea Syndrome Complex Sleep Apnea Syndrome
By Product Type	Diagnostic Devices Therapeutic Devices Sleep Apnea Masks
By Patient Demographics	Pediatric Adult Geriatric
By End User	Hospital Diagnostics Centers Ambulatory Care Centers Specialty Care Centers Home Healthcare
By Distribution Channel	Direct Tender Retail Sales

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of sleep apnea devices is estimated at USD 10.98 billion.

The sleep apnea devices market size was valued at USD 10.38 billion in 2024 and is set to cross USD 25.51 billion by the end of 2037, registering more than 7.1% CAGR during the forecast period i.e., between 2025-2037. Growing demand for home sleep apnea tests and advanced innovations in technology for devices will boost the market growth.

Asia Pacific industry is likely to hold majority revenue share by 2037, propelled by growing geriatric population along with rising prevalence of diseases such as cardiovascular diseases, cancer, hypertension, and diabetes in the region.

The major players in the market include Philips Respironics, BMC Medical Co. ltd., Curative Medical Inc., SOMNOmedics GmbH, Itamar Medical Ltd., Nihon Kohden Corporation, ResMed INC., Natus Medical Incorporated, Invacare Corporation, Compumedics Limited.

Sleep Apnea Devices Market Analysis